Skip to main content
Fig. 2 | Genome Biology

Fig. 2

From: Cancer biomarker discovery is improved by accounting for variability in general levels of drug sensitivity in pre-clinical models

Fig. 2

General levels of drug sensitivity in a panel of cancer cell lines. a The proportion of variability in the data explained by each of the PCs of the fully imputed drug sensitivity (IC50) data matrix in CGP. PCs are arranged by associated eigenvalue. b Histogram of Spearman correlations of the IC50 values of all 138 drugs in CGP with PC1 of the fully imputed IC50 matrix. c Boxplot of PC1 (estimated in all 714 cell lines) against tissue-of-origin in CGP. Boxes are colored by cancer type

Back to article page